DENALI ADVISORS LLC - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 43 filers reported holding PSYCHEMEDICS CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DENALI ADVISORS LLC ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q4 2019$1,0000.0%980.0%0.00%
Q3 2019$1,000
-50.0%
98
-46.2%
0.00%
Q2 2019$2,000
+100.0%
182
+116.7%
0.00%
Q1 2019$1,0000.0%840.0%0.00%
Q4 2018$1,0000.0%84
+110.0%
0.00%
Q3 2018$1,000
-50.0%
40
-50.0%
0.00%
Q2 2018$2,0000.0%800.0%0.00%
Q1 2018$2,0000.0%800.0%0.00%
Q4 2017$2,000
+100.0%
80
+33.3%
0.00%
Q3 2017$1,000600.00%
Other shareholders
PSYCHEMEDICS CORP shareholders Q4 2019
NameSharesValueWeighting ↓
22NW, LP 274,418$1,089,4390.78%
WEALTH EFFECTS LLC 40,701$161,5820.08%
Cannell Capital 74,794$296,9320.07%
SANTA MONICA PARTNERS LP 20,000$790.06%
RBF Capital, LLC 144,231$572,5970.04%
WEDBUSH SECURITIES INC 42,414$1680.01%
Ancora Advisors LLC 78,373$311,1410.01%
Your Advocates Ltd., LLP 1,400$5,5580.00%
CRAWFORD INVESTMENT COUNSEL INC 32,098$127,4280.00%
Renaissance Technologies 273,663$1,0860.00%
View complete list of PSYCHEMEDICS CORP shareholders